ICON PUBLIC LIMITED COMPANY
StreetZero Signal 63
About ICON PUBLIC LIMITED COMPANY
ICON Public Limited Company (NASDAQ:ICLR) is a clinical research organization headquartered in Dublin, Ireland. It provides outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries, including clinical trial management and related support. The company is publicly traded and operates as a B2B service provider in the biotechnology research sector.
LATEST FUNDINGRule 144
$2.0M
Announced 2026-11-12
IN THE NEWS
- 🔗 ICON Public Limited Company (ICLR) Fell on Reduced Guidance
- 🔗 ICON plc
- 🔗 Is ICON Public Limited Company (ICLR) A Good Stock To Buy Now?
- 🔗 What Makes ICON Public Limited Company (ICLR) a High-Quality Contender in the CRO Industry?
- 🔗 ICON Public Limited Company (ICLR) Stock Price, News, Quote & History - Yahoo Finance
EMPLOYEES—
FOUNDED—
HQDublin, Ireland
Industry
Public Equity (NASDAQ)
Tags
B2BClinical ResearchBiotechnologyPublic Company
Investors
Key highlights
- Publicly traded CRO on NASDAQ under ticker ICLR.
- Provides mission-critical services to pharma and biotech clients.
- Generated over $1B in annual free cash flow.
- Headquartered in Dublin with global operations.
Ask StreetZero about ICON PUBLIC LIMITED COMPANY
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account